United Kingdom · Question · Written question
HL HL2250
Osteoporosis: Screening
Introduced
6 February 2024
Last action
13 February 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 February 2024
Summary
To ask His Majesty's Government whether they are considering using the new screening technology, developed by OsteoSight, for estimating bone mineral density from routine X-rays that has been approved by the Food and Drug Administration in the United Stat
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
6 February 2024
Written question
To ask His Majesty's Government whether they are considering using the new screening technology, developed by OsteoSight, for estimating bone mineral density from routine X-rays that has been approved by the Food and Drug Administration in the United Stat
Source: Lords
13 February 2024
Answer
OsteoSight is not a registered product with the Medicines and Healthcare Products Regulatory Agency, therefore the Government is not currently considering the use of this technology. However, we will continue to explore areas where artificial intelligence...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-02-06/HL2250
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1688051
- uk · wq-1688051 · source updated 13 February 2024